. Author manuscript; available in PMC: 2009 Oct 1.

Published in final edited form as: J Am Med Dir Assoc. 2008 Oct;9(8):558–564. doi: 10.1016/j.jamda.2008.03.003

Table 4.

Prevalence Rates of Medications with Non-Oral Modes of Administration or that Require Additional Monitoring

Non-Oral Modes of Administration	Frequency (%)
Insulin Injections	11 (5.6%)
Eye Drops	26 (13.1%)
Inhaler/Nebulizer Therapy	19 (9.6%)
Any of the above	50 (25.3%)
Additional Monitoring Required
Diabetes therapy	29 (14.6%)
Cancer therapy	7 (3.5%)
Prednisone	3 (1.5%)
Seizure Disorder	24 (12.1%)
Digoxin	27 (13.6%)
Thyroid	32 (16.2%)
Warfarin Therapy	15 (7.6%)
Any of the above	98 (49.5%)